Liver malignant tumor patient
Conditions
Interventions
date:9/2014-3/2016 dose:400MBq frequency:1
Sponsors
Hokkaido University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The person whom I can agree with 2.The person whom I can agree with
Exclusion criteria
Exclusion criteria: 1.Face up position rest is not possible,claustrophobia 2.Judgment of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUV(Standardized Uptake Value) Tumor/blood ratio Tumor/muscle ratio | — |
Countries
Japan
Contacts
Public ContactTohru Shiga
Hokkaido University Depertment of Nuclear Medicine
Outcome results
None listed